Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Horaud

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Developments in Biological Standardization|January 1, 1991
European project concerning the guidelines on medicinal products derived from human blood and plasmaF Horaud
Developments in Biological Standardization|January 1, 1991
Introductory remarks: viral safety of biologicalsF Horaud
Developments in Biological Standardization|January 1, 1994
A view on regulatory aspects of live viral vaccine safetyF Horaud
Developments in Biological Standardization|January 1, 1993
Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strainsF Horaud
Biologicals : Journal of the International Association of Biological Standardization|December 1, 1993
Albert B. SabinJ L Melnick, F Horaud
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 19, 2001
Polio vaccine and retrovirusesJ Beale, F Horaud
Reviews of Infectious Diseases|May 1, 1984
Antigenic variation of poliovirus studied by means of monoclonal antibodiesR Crainic, B Blondel, F Horaud
Developments in Biological Standardization|January 1, 1985
A rabies vaccine produced in a non-tumorigenic rabbit cell lineP Sureau, P Perrin, F Horaud
Developments in Biological Standardization|January 1, 1983
Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptideR Crainic, B Blondel, F Horaud
Virology|January 1, 1990
Poliovirus permissivity and specific receptor expression on human endothelial cellsT Couderc, T Barzu, F Horaud, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Developments in Biological Standardization|January 1, 1991
European project concerning the guidelines on medicinal products derived from human blood and plasmaF Horaud
Developments in Biological Standardization|January 1, 1991
Introductory remarks: viral safety of biologicalsF Horaud
Developments in Biological Standardization|January 1, 1994
A view on regulatory aspects of live viral vaccine safetyF Horaud
Developments in Biological Standardization|January 1, 1993
Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strainsF Horaud
Biologicals : Journal of the International Association of Biological Standardization|December 1, 1993
Albert B. SabinJ L Melnick, F Horaud
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 19, 2001
Polio vaccine and retrovirusesJ Beale, F Horaud
Reviews of Infectious Diseases|May 1, 1984
Antigenic variation of poliovirus studied by means of monoclonal antibodiesR Crainic, B Blondel, F Horaud
Developments in Biological Standardization|January 1, 1985
A rabies vaccine produced in a non-tumorigenic rabbit cell lineP Sureau, P Perrin, F Horaud
Developments in Biological Standardization|January 1, 1983
Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptideR Crainic, B Blondel, F Horaud
Virology|January 1, 1990
Poliovirus permissivity and specific receptor expression on human endothelial cellsT Couderc, T Barzu, F Horaud, et al.
Pageof 4